Neuropore Therapies, Inc
Neuropore Therapies, Inc. is a San Diego-based biopharmaceutical company dedicated to discovering innovative therapeutics that target the underlying causes of neurodegenerative diseases, with the mission of halting their progression. Their current clinical trials include the Phase 2 study of UCB0599 in patients with early-stage Parkinson's disease, and they have recently received a substantial grant from The Michael J. Fox Foundation for Parkinson's Research to support the development of their TLR2 program.
With a team of experts and strategic partnerships with corporate foundations and academic institutions, Neuropore Therapies is well-positioned to make significant advancements in the field of neurodegenerative disease research. Their publications highlight the promising effects of their small molecule, NPT200-11, in a transgenic mouse model of Parkinson's disease, demonstrating their commitment to finding potential therapeutic solutions. Located in San Diego, California, Neuropore Therapies is dedicated to making a positive impact on the lives of individuals affected by neurodegenerative diseases.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Partial Data by Foursquare.